(BLCO) Bausch + Lomb - Ratings and Ratios

Bausch + Lomb Corporation is a global eye health company with a diverse portfolio of products and services across three key segments: Vision Care, Pharmaceuticals, and Surgical. The company offers a wide range of contact lenses, lens care products, and eye health supplements, as well as pharmaceutical products for post-operative care and treatment of various eye conditions. Its Surgical segment provides advanced medical devices and technologies for cataract surgery and other eye procedures. With a presence in over 15 countries, Bausch + Lomb Corporation leverages a combination of direct sales forces and independent distributors to reach its customers.

The companys history dates back to 1853, and it is now a subsidiary of Bausch Health Companies Inc., with its headquarters in Vaughan, Canada. As a leading player in the eye health industry, Bausch + Lomb Corporation is well-positioned to capitalize on the growing demand for eye care products and services driven by an aging population and increasing prevalence of eye diseases.

Analyzing the , we observe that the stocks last price is $11.70, with a 20-day SMA of $11.58 and a 50-day SMA of $12.14, indicating a potential bullish crossover. The 200-day SMA stands at $16.49, suggesting a longer-term downtrend. The ATR of 0.53 represents a 4.56% daily volatility. Given the current price action and indicating a forward P/E of 20.96, we can forecast a potential price target. If the company can demonstrate improved profitability and stabilize its RoE, the stock may experience a rebound. Based on the current and , a possible forecast is that the stock price may rise to $15.00 within the next 6-12 months, driven by a combination of improved earnings and a potential reversal of the downtrend.

To achieve this forecast, Bausch + Lomb Corporation will need to focus on executing its business strategy, driving growth in its key segments, and improving its profitability. The companys ability to innovate and expand its product portfolio, as well as its capacity to navigate the competitive landscape, will be crucial in determining its future success. With a market capitalization of $4.07 billion and a presence in multiple countries, Bausch + Lomb Corporation has the scale and resources to invest in growth initiatives and drive long-term value creation.